Market Research Report
Global Cellbag Bioreactor Chambers Market Outlook 2020-2030
|Global Cellbag Bioreactor Chambers Market Outlook 2020-2030|
Published: January 24, 2022
Content info: 208 Pages
Delivery time: 1-2 business days
The global cellbag bioreactor chambers market is anticipated to grow with a CAGR of 12.7% over the forecast period, i.e., 2021 - 2030. Factors such as the increasing trends of cell culture in the field of cellular and molecular biology, along with the growing research and developments in the field of healthcare are projected to drive the market growth. Moreover, factors such as the increasing prevalence of chronic diseases around the globe and the surge in use of stem cell therapies for the treatment of these chronic diseases, along with other diseases, such as for treating spinal cord injuries, Parkinson's disease, diabetes, Alzheimer's disease, and stroke among others are also anticipated to boost the market growth during the forecast period. The global cellbag bioreactor chambers market is estimated to garner a revenue of more than USD 5120 Million by the end of 2030, up from a revenue of near to USD 1550 Million in the year 2020.
The global cellbag bioreactor chambers market is segmented by numerous segments, which include segmentation by material, component, application, scale, end-user, and by region. By material, the market is segmented into ethylene vinyl acetate copolymer, low density polyethylene, thermoplastic elastomer, polyester, polypropylene, and others. The polypropylene segment, out of all the other segments, is anticipated to garner the largest revenue of around USD 1260 Million by the end of 2030, up from a revenue of close to USD 370 Million in the year 2020.
On the basis of regional analysis, the global cellbag bioreactor chambers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America, amongst the market in all the other regions, is anticipated to garner the largest revenue of near to USD 2270 Million by the end of 2030, up from a revenue of about USD 720 Million in the year 2020.
Some of the prominent industry leaders in the global cellbag bioreactor chambers market that are included in our report are: Thermo Fisher Scientific, Avantor, Inc., Global Life Sciences Solutions USA LLC (Cytiva), Sartorius AG, Pall Corporation, Celltainer Biotech BV, Adolf Kuhner AG, Merck KGaA, TERUMO BCT, INC., and others.